Corbus Pharmaceuticals (CRBP) announced the appointment of Winston Kung to its Board of Directors. The appointment was effective as of August 16, 2024. Mr. Kung will also chair the Audit Committee. Currently, Kung serves as Chief Financial Officer of Arrivent BioPharma (AVBP)
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRBP:
- Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung
- Corbus Pharmaceuticals participates in a conf call hosted by Cantor Fitzgerald
- Corbus Pharmaceuticals price target raised to $88 from $80 at Oppenheimer
- Corbus Pharmaceuticals Shares Updated Corporate Presentation
- Corbus Pharmaceuticals Shares Operational Insights with SEC